Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Febrile neutropenia].

Frank Bally1, Oscar Marchetti, Alain Cometta

  • 1Service des maladies infectieuses, département de médecine interne, centre hospitalier universitaire vaudois, CH-1011 Lausanne, Suisse.

La Revue Du Praticien
|March 11, 2004
PubMed
Summary

Early broad-spectrum antibiotics significantly reduce infection mortality in cancer patients with chemotherapy-induced neutropenia. Oral antibiotics are effective for low-risk patients, with outpatient management under investigation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Epidemiology, Risk Factors, and Outcomes of Neutropenic Enterocolitis in Onco-Hematological Patients According to Chemotherapy Regimen.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2025
Same author

[Pericarditis: state-of-the art and perspectives in 2025].

Revue medicale suisse·2025
Same author

Serial monitoring of pancreatic stone protein for the detection of sepsis in intensive care unit patients with complicated abdominal surgery: A prospective, longitudinal cohort study.

Journal of critical care·2024
Same author

[Infectious diseases: what's new in 2023].

Revue medicale suisse·2024
Same author

Revue medicale suisse·2023
Same author

[Duration of antibiotic therapy for common respiratory infections in adults].

Revue medicale suisse·2023

Area of Science:

  • Oncology
  • Infectious Diseases
  • Pharmacology

Background:

  • Chemotherapy-induced neutropenia frequently leads to infections in cancer patients.
  • Early broad-spectrum antibiotic administration is critical for managing infections and reducing mortality in granulocytopenic patients.
  • Intravenous broad-spectrum beta-lactam monotherapies are effective and well-tolerated treatments.

Purpose of the Study:

  • To review the management of infections in cancer patients experiencing chemotherapy-related neutropenia.
  • To differentiate between high-risk and low-risk patients for infectious complications.
  • To evaluate the efficacy of oral versus intravenous antibiotic regimens for febrile neutropenia.

Main Methods:

  • Analysis of outcomes in febrile neutropenic cancer patients.
  • Comparison of intravenous and oral antibiotic regimens.
  • Risk stratification for infectious complications.

Main Results:

  • Empiric broad-spectrum antibiotics have dramatically decreased infection-related mortality.
  • Broad-spectrum beta-lactam monotherapies are effective intravenous options.
  • Oral antibiotic regimens are as effective as intravenous regimens in low-risk patients.

Conclusions:

  • Risk stratification is essential for tailoring neutropenia infection management.
  • Oral antibiotics represent an effective alternative to intravenous therapy for low-risk patients.
  • Further research is needed to establish the benefits and limitations of outpatient management for febrile neutropenia.

Related Experiment Videos